Brevan Howard Capital Management’s Revolution Medicines RVMD Stock Holding History

Brevan Howard Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.61M	Sell	16,505 -16,302	-50%	-$1.65M	0.01%	662
2025 Q4	$2.61M	Buy	32,807 +1,644	+5%	+$108K	0.03%	396
2025 Q3	$1.46M	Sell	31,163 -172,957	-85%	-$6.77M	0.01%	721
2025 Q2	$7.51M	Buy	+204,120	New	+$7.84M	0.04%	248
2025 Q1	–	Sell	-41,884	Closed	-$1.83M	–	1417
2024 Q4	$1.83M	Buy	41,884 +30,796	+278%	+$1.55M	0.01%	303
2024 Q3	$503K	Sell	11,088 -3,613	-25%	-$157K	﹤0.01%	677
2024 Q2	$571K	Sell	14,701 -4,235	-22%	-$158K	0.01%	556
2024 Q1	$610K	Buy	+18,936	New	+$561K	0.01%	396

Other funds holding RVMD

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brevan Howard Capital Management's RVMD Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Revolution Medicines (RVMD) stake by 50% in Q1 2026, selling an estimated $1.65M and leaving 16,505 shares worth $1.61M. The position accounts for 0.01% of the portfolio, ranked #662.

Brevan Howard Capital Management first reported a position in RVMD in Q1 2024 and has held it in 8 quarters since. The position peaked at $7.51M in Q2 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

Brevan Howard Capital Management held 16,505 shares of Revolution Medicines worth $1.61M as of Q1 2026.
Brevan Howard Capital Management sold 16,302 Revolution Medicines shares in Q1 2026, an estimated $1.65M.
Revolution Medicines made up 0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #662 holding.
Brevan Howard Capital Management first reported a position in Revolution Medicines in Q1 2024 and has held it in 8 quarters since.
Brevan Howard Capital Management's Revolution Medicines position peaked at $7.51M in Q2 2025.
512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.